The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Until today this year the stock’s price performance recorded a decrease of -92.25%. However, over the last six months, the performance has been stronger by -87.24%. The price of ADAP decreased -71.75% over the last 30 days. And in the last five days, it has fallen by -3.00%.
Adaptimmune Therapeutics Plc ADR (ADAP) current stock price is $0.08. During the last trading session, the stock soared, reaching $1.5 after opening at $0.08. The stock’s lowest point was $0.11 before it closed at $0.08.
In terms of market performance, Adaptimmune Therapeutics Plc ADR had a somewhat inconsistent run in.
52-week price history of ADAP Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Adaptimmune Therapeutics Plc ADR’s current trading price is -94.17% away from its 52-week high, while its distance from the 52-week low is 9.15%. The stock’s price range over this timeframe has been between $0.07 and $1.33. The shares of the Healthcare sector company recorded a trading volume of approximately 25.71 million for the day, which was comparatively higher than the average daily volume of 16.19 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Adaptimmune Therapeutics Plc ADR (ADAP) has experienced a quarterly decline of -74.17% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 19.98M and boasts a workforce of 506 employees.
Expert Opinions: Analysts’ Ratings for Adaptimmune Therapeutics Plc ADR
As of right now, 0 analyst is rating Adaptimmune Therapeutics Plc ADR as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 4 analysts are recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2522, with a change in price of -0.3792. Similarly, Adaptimmune Therapeutics Plc ADR recorded 11,225,045 in trading volume during the last 100 days, posting a change of -83.03%.
ADAP Stock Stochastic Average
The raw stochastic average for Adaptimmune Therapeutics Plc ADR over the last 50 days is presently at 2.27%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 2.27%. Further, the company’s Stochastic %K and %D values for the last 20 days were 3.23% and 4.45%, respectively.
